Astrana Health, Inc. (ASTH) Stock AnalysisASTHStock AnalysisAstrana Health, Inc.

Astrana Health, Inc. is a physician-centric, artificial intelligence (AI)-powered healthcare company focused on delivering patient-centered care. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. It supports more than 20,000 providers. It operates in the Healthcare sector (MANAGEMENT CONSULTING SERVICES industry).

Astrana Health Inc is a good buy right now due to its impressive revenue growth of 55.4% over the past two years and a current price of $37.96, which is significantly lower than the average analyst price target of $55. This suggests substantial upside potential. Additionally, the company has shown a positive trend in earnings with an EPS of $0.40 reported in Q2, exceeding estimates by 29.03%. However, the RSI is at 45.75, indicating it is nearing oversold territory, which could present a risk if momentum does not improve.